About this document

Update on CABP Pharmacotherapy by tcrosca is a document available to read on EtoBox.

This article summarizes a study comparing the safety and efficacy of two new antibiotics, ceftaroline fosamil and tigecycline, for the treatment of community-acquired bacterial pneumonia. Ceftaroline fosamil and tigecycline were both recently approved by the FDA as treatment options for CABP. The article reviews two phase III clinical trials that compared ceftaroline fosamil to ceftriaxone for treating hospitalized CABP patients. The trials found that ceftaroline fosamil was generally well tolerated with a

Author

tcrosca

Language

EN